Skip to main content
Brenton Mar, MD, Pediatric Hematology & Oncology, Cambridge, MA

BrentonGarrettMarMDPhD

Pediatric Hematology & Oncology Cambridge, MA

Pediatric Hematologic Oncology

SVP, Head of Clinical Development, Relay Therapeutics

Dr. Mar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mar's full profile

Already have an account?

  • Office

    399 Binney Street
    Cambridge, MA 02142

Summary

  • I'm a physician-scientist and Head of Clinical Development focused on growing and nurturing an incredibly smart and hard-working team of physicians and scientists in the Clinical Development, Clinical Science, Translational Medicine, Pharmacovigilance and Medical Writing groups at Relay Therapeutics. Our goal is to bring transformational new therapies to patients living with cancers and rare diseases through seamless clinical development from phase one to registration.

    My experiences span solid tumors and heme malignancies, from INDs and first-in-human phase ones to registrational Phase 2 and 3 randomized trials and an sNDA. I have driven clinical development and publication strategy, advisory boards, interacted with FDA, EMA and country level authorities in Europe and Asia, been involved with analyst interactions, business development/diligence and portfolio management. My research background includes genomics, targeted therapies, precision oncology molecular and computational biology.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Pediatrics, 2006 - 2009
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2019
  • NY State Medical License
    NY State Medical License 2007 - 2009

Publications & Presentations

PubMed

Journal Articles

  • PPM1D Truncating Mutations Confer Resistance to Chemotherapy and Sensitivity to PPM1D Inhibition in Hematopoietic Cells  
    Peter G Miller, Brenton Mar, Benjamin L Ebert, Shaunt Fereshetian, Anthony Letai, Siddhartha Jaiswal, Blood

Press Mentions

  • Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study Finds
    Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 9th, 2017
  • Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study Finds
    Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017
  • Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study Finds
    Genetic Profiling Can Guide Stem Cell Transplantation for Patients with Myelodysplastic Syndrome, Study FindsFebruary 8th, 2017